Skip to content

Drug interactions

Amlodipine-hydrochlorothiazide-valsartan + Paclitaxel protein bound

Severity: Minor

Amlodipine-hydrochlorothiazide-valsartan and Paclitaxel protein bound: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Valsartan is a substrate of hepatic uptake transporters, and OATP1B1 inhibition could increase its exposure. Paclitaxel is not an established clinically significant inhibitor of this transporter, so any effect is theoretical.

What this interaction means in plain words

Amlodipine-hydrochlorothiazide-valsartan and Paclitaxel protein bound have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Possible inhibition of OATP1B1-mediated hepatic uptake of valsartan; not established clinically.

What to do

No specific action is needed beyond routine monitoring of blood pressure during chemotherapy.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Amlodipine-hydrochlorothiazide-valsartan and Paclitaxel protein bound, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Amlodipine-hydrochlorothiazide-valsartan with Paclitaxel protein bound?

MediHelp rates the interaction as minor. Amlodipine-hydrochlorothiazide-valsartan and Paclitaxel protein bound have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Valsartan is a substrate of hepatic uptake transporters, and OATP1B1 inhibition could increase its exposure. Paclitaxel is not an established clinically significant inhibitor of this transporter, so any effect is theoretical.

How serious is the interaction between Amlodipine-hydrochlorothiazide-valsartan and Paclitaxel protein bound?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No specific action is needed beyond routine monitoring of blood pressure during chemotherapy.

What other medicines interact with Amlodipine-hydrochlorothiazide-valsartan?

MediHelp also lists interactions of Amlodipine-hydrochlorothiazide-valsartan with, for example, Aliskiren, Dofetilide, Sparsentan. The full list is on the Amlodipine-hydrochlorothiazide-valsartan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in